Skip to Main Content
Jennifer Gill, M.D.,  Ph.D.

Jennifer Gill, M.D., Ph.D.

Titles and Appointments

Assistant Professor

School
Graduate School
Department
Dermatology
Graduate Programs
Cancer Biology

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

  • Biography

    Dr. Gill received her M.D. and Ph.D. (Immunology) degrees from the Medical Scientist Training Program at Washington University Medical School in St. Louis. Prior to joining the faculty, she completed her dermatology residency and a cancer biology postdoctoral fellowship at the University of Texas Southwestern Medical Center. She is board-certified by the American Board of Dermatology and sees patients with melanoma and advanced skin cancer in her dermatology clinic at UTSW Professional Office Building 2.

    In addition to clinical work, Dr. Gill runs a research laboratory focused on understanding the molecular and metabolic regulators of melanoma. Her specific interests include 1) Characterizing the role of the enzyme GAPDHS in melanoma progression and metastasis; 2) Determining how tumor metabolism impacts melanoma behavior, therapeutic response, and patient outcomes; and 3) Leveraging clinical and translational studies in patients to teach us about melanoma biology.

  • Education
    Graduate School
    Washington University School of Medicine in St. Louis (2012)
    Medical School
    Washington University School of Medicine (2012)
    Other Post Graduate Training
    Washington University School of Medicine in St. Louis (2012)
    Internship
    Texas Health Presbyterian Hospital Dallas (2013), Internal Medicine
    Residency
    UT Southwestern Medical Center (2016), Dermatology
  • Research Interest
    • Cancer metastasis
    • Melanoma metastasis
    • Targeted therapies for treatment of cancer
  • Publications
    Acral melanoma in a United States safety net hospital: retrospective cohort study
    Dubocq-Ortiz C, Encarnacion-Cortes V, Gill JG, Vasquez R Archives of Dermatological Research 2025 Dec 317
    Conservation and divergence of metabolic phenotypes between patient tumours and matched xenografts
    Rao AD, Cai L, Snyman M, Walsdorf RE, Li X, Wix SN, Gard G, Brown AB, Kim J, Santos Patricio J, Muh S, Martin Sandoval M, Zacharias LG, Heimdal KA, Gu W, Homsi J, Tillman B, Sharma R, Vandergriff TW, Solmonson A, Faubert B, Mathews TP, Morrison SJ, DeBerardinis RJ, Gill JG Nature Metabolism 2025 Aug 7 1703-1713
    Language barriers are associated with advanced presentation of melanoma in Hispanic patients: A retrospective case series
    Brown AB, Wix SN, Yip CH, Mafong K, Wu M, Wang D, Zhang S, Vasquez R, Li M, Gill JG Journal of the American Academy of Dermatology 2025 94 680-683
    Types and severity of cutaneous toxicities to BRAF inhibitors are drug-specific and discrete: A single-center cohort study
    Sarlashkar P, Gill JG, Heberton M Journal of the American Academy of Dermatology 2024 Nov 91 945-948
    Pathogenic mitochondrial DNA mutations inhibit melanoma metastasis
    Shelton SD, House S, Melo LM, Ramesh V, Chen Z, Wei T, Wang X, Llamas CB, Venigalla SS, Menezes CJ, Allies G, Krystkiewicz J, Rösler J, Meckelmann SW, Zhao P, Rambow F, Schadendorf D, Zhao Z, Gill JG, DeBerardinis RJ, Morrison SJ, Tasdogan A, Mishra P Science Advances 2024 Nov 10
    Increased presentation for vitiligo cutaneous immune related adverse events in Hispanic patients
    Momin ZK, Gill JG, Heberton M Archives of Dermatological Research 2024 Aug 316
    The metabolism of melanin synthesis—From melanocytes to melanoma
    Snyman M, Walsdorf RE, Wix S, Gill JG Pigment Cell and Melanoma Research 2024 Jul 37 438-452
    Understanding the Association Between Social Determinants of Health and Receipt of Immunotherapy for Melanoma
    Ramirez F, Vasquez R, Gill J, Riva H, Zambrano A, Samaniego M, Fernandez L, Chacon J Journal of Drugs in Dermatology 2024 May 23 311-315
    Clinical Features and Outcomes of Black Patients with Melanoma
    Wix SN, Brown AB, Heberton M, Adamson AS, Gill JG JAMA Dermatology 2024 Mar 160 328-333
    Tumoral melanosis: A case series of patients with metastatic melanoma after systemic immunotherapy
    Wix SN, Heberton M, Vandergriff TW, Yancey KB, Gill JG JAAD Case Reports 2024 Mar 45 82-87
  • Books

    Featured 

  • Honors & Awards
    • Doris Duke Clinician Scientist Development Award
      (2023)
    • Disease Oriented Clinical Scholar (DOCS) Award
      (2022)
    • American Academy of Dermatology Presidential Citation Award
      (2018)
    • Dermatology Foundation Physician-Scientist Career Development Award
      (2017)
    • Dermatologist Investigator Research Fellowship
      (2016)
    • UTSW Dermatology Resident Award for Leadership
      (2016)
    • Dermatology Resident Award for Humanism and Professionalism
      (2015)
    • Texas Health Presbyterian Hospital Intern of the Year Award
      (2013)
    • Barry M. Goldwater National Scholarship
      (2002)
    • University of Georgia Foundation Fellowship Scholarship
      (1999-2003)
  • Professional Associations/Affiliations
    • American Academy of Dermatology (2013)
    • American Association for Cancer Research (2023)
    • Society for Investigative Dermatology (2013)
    • Society for Melanoma Research (2021)